Cardlytics Q3 revenue drops 30% to $32.9 million; Q4 outlook below prior year
Cardlytics reported third-quarter 2026 revenue of $32.9 million, down 30% from a year earlier, and billings of $57.2 million, down 32%. CEO Amit Gupta said results came in below expectations, and the company guided fourth-quarter revenue to $35.0 million to $39.0 million, which is still a year-over-year decline, though management expects sequential growth.
Key points
- Q3 2026 revenue was $32.9 million, down 30% from $47.0 million in Q3 2025; billings were $57.2 million, down 32%.
- Net loss narrowed to $(8.9) million from $(72.7) million a year earlier, when results included a $58.8 million impairment of goodwill and intangible assets.
- Adjusted EBITDA was $0.4 million, compared with $3.3 million in Q3 2025.
- Q4 2026 guidance: revenue of $35.0 million to $39.0 million (down 31% to 23% year over year) and Adjusted EBITDA of $(1.0) million to $2.0 million.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.